Latest News

MassSpec pen delivers real-time cancer diagnosis in seconds

A team of scientists and engineers at The University of Texas at Austin has invented a powerful tool that rapidly and accurately identifies cancerous tissue during surgery, delivering results in about ....

Conference Spotlight

Precision Medicine World Conference (PMWC) 2018

PMWC 2018 Silicon Valley on January 22-24, co-hosted by Stanford Health Care, UCSF, Duke Health, and Duke University, covers all facets of Precision Medicine including current hot topics like immunotherapy, the Precision Medicine Initiative, liquid biopsy, the human microbiome, big data, and cancer & companion diagnostics.


On study designs and hypotheses for clinical trials with predictive biomarkers.

Recent interest in conducting clinical trials with predictive biomarkers has generated research in comparing relative efficiency of different trial designs. We find these comparisons of efficiency mos ....

Decision Algorithms

Physician Experiences and Understanding of Genomic Sequencing in Oncology.

The amount of information produced by genomic sequencing is vast, technically complicated, and can be difficult to interpret. Appropriately tailoring genomic information for non-geneticists is an esse ....

Product News

Genomic Health and Biocartis to develop IVD version of Oncotype DX

REDWOOD CITY. Genomic Health, Inc., the world’s leading provider of genomic-based diagnostic tests  and Biocartis Group NV, an innovative molecular diagnostics company, today announced an exclu ....


Imaging the emergence and natural progression of spontaneous autoimmune diabetes.

Type 1 diabetes in the nonobese diabetic mouse stems from an infiltration of the pancreatic islets by a mixed population of immunocytes, which results in the impairment and eventual destruction of ins ....


The Epigenomic Analysis of Human Obesity.

Analysis of the epigenome-the chemical modifications and packaging of the genome that can influence or indicate its activity-enables molecular insight into cell type-specific machinery. It can, theref ....

Pipeline News

Daiichi Sankyo Initiates Phase 1/2 Study of Novel Antibody Drug Conjugate U3-1402 in Patients with HER3-Positive Metastatic or Unresectable Breast Cancer

TOKYO. Daiichi Sankyo Company, Limited announced today the initiation of a three-part open-label phase 1/2 study in Japan with U3-1402, a novel HER3-targeting antibody drug conjugate, in patients with ....

Issued Patents

Blood Markers For Diagnosing Epithelium Derived Cancers And Monoclonal Antibodies Thereof

The present invention provides uses of cytokeratins as markers for diagnosing epithelium derived cancers. The present invention provides cancer-related epitopes of cytokeratins and monoclonal antibodi ....

Patent Applications

Dna-decorated Graphene Chemical Sensors

The present invention provides a broad response single-stranded DNA-graphene chemical sensor device. The present invention also provides methods for improving the ability of graphene to work as a chem ....


Automating Construction of Machine Learning Models With Clinical Big Data: Proposal Rationale and Methods.

To improve health outcomes and cut health care costs, we often need to conduct prediction/classification using large clinical datasets (aka, clinical big data), for example, to identify high-risk pati ....

Funding News
Sensors and Wearables

Fluorescent sensors may effectively treat solid-tumor cancers

BUFFALO. For several decades, scientists have recognized the key role that a molecule known as GTP, one of the building blocks of RNA, plays in the development of cancer and other diseases. But they h ....

Recruiting Trials

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

To prospectively collect blood and tumor tissue from esophageal cancer patients to identify specific esophageal cancer mutations that can be measured in the blood (cell free DNA) during the cour ....